CD8A and hepatocellular carcinoma: The results showed that HCC patients with high expression of ASF1B had higher recurrence rates in the decreased B cells [hazard ratio (HR)=1.77, P=0.016], decreased CD8+ T cells (HR=1.84, P=0.012), and decreased neutrophils (HR=1.93, P=0.01) subgroups (Figures 10A, C, E).